GenMont Biotech Incorporation (TPE:3164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.40
-0.10 (-0.57%)
May 8, 2026, 1:22 PM CST

TPE:3164 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,4971,5781,7482,1372,0472,103
Market Cap Growth
-5.73%-9.68%-18.22%4.39%-2.67%9.23%
Enterprise Value
1,3421,4811,7062,0221,8181,937
Last Close Price
17.4017.5618.6422.3320.8520.48
PE Ratio
33.4127.5930.5264.7735.9318.59
PS Ratio
3.833.934.546.725.554.92
PB Ratio
1.061.091.181.481.371.38
P/TBV Ratio
1.171.191.301.631.521.53
P/FCF Ratio
27.6722.4921.871655.1831.11-
P/OCF Ratio
25.9921.4514.1061.7614.9418.84
EV/Sales Ratio
3.433.694.436.364.934.53
EV/EBITDA Ratio
12.6112.2915.7729.3916.5413.54
EV/EBIT Ratio
32.8425.6541.98289.2929.3415.49
EV/FCF Ratio
24.8121.1021.351565.8627.64-
Debt / Equity Ratio
0.080.080.080.040.020.02
Debt / EBITDA Ratio
1.060.891.060.810.310.22
Debt / FCF Ratio
2.091.571.4945.160.53-
Net Debt / Equity Ratio
-0.19-0.18-0.16-0.19-0.24-0.25
Net Debt / EBITDA Ratio
-2.65-2.12-2.22-3.93-3.33-2.72
Net Debt / FCF Ratio
-5.08-3.63-3.00-209.14-5.5773.63
Asset Turnover
0.230.240.230.190.220.26
Inventory Turnover
2.152.021.781.492.423.58
Quick Ratio
2.083.182.802.522.823.43
Current Ratio
2.774.283.873.183.244.17
Return on Equity (ROE)
2.50%3.28%3.26%1.52%3.14%7.29%
Return on Assets (ROA)
1.48%2.14%1.51%0.26%2.28%4.72%
Return on Invested Capital (ROIC)
2.57%3.57%2.48%0.48%3.92%8.99%
Return on Capital Employed (ROCE)
2.70%3.80%2.60%0.50%4.00%8.00%
Earnings Yield
3.00%3.62%3.28%1.54%2.78%5.38%
FCF Yield
3.61%4.45%4.57%0.06%3.21%-0.25%
Dividend Yield
4.60%4.56%4.29%2.24%3.36%5.37%
Payout Ratio
154.18%121.00%75.56%183.26%166.75%53.42%
Buyback Yield / Dilution
0.83%0.23%-0.18%0.10%0.09%1.50%
Total Shareholder Return
5.43%4.79%4.11%2.34%3.45%6.87%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.